Actigraphy appears to be a feasible objective tool for sleep assessment in SUDs, though additional studies across diverse substances are needed.
Actigraphy appears to be a feasible objective tool for sleep assessment in SUDs, though additional studies across diverse substances are needed.
Interactive sVMs can effectively dispense HR items and connect individuals to services, thereby having the potential to improve individual and public health. Contextual factors, such as location, may influence utilization.
Single-item patient-reported outcome measures are pragmatic tools for implementing measurement-based care in substance use treatment.
Symptom-based dosing decreased time to medical readiness for discharge compared with a scheduled opioid taper approach among infants cared for with ESC.
These results demonstrate substantial missed opportunities for MOUD treatment during pregnancy, highlighting the need for targeted interventions to improve evidence-based perinatal OUD care.
This cross-sectional study found a substantial increase in the percentage of individuals with OUD who received MOUD among almost all states.
Medicaid managed care plans located in Republican-leaning states were less likely to be subject to state requirements governing coverage and prior authorization of SUD treatment medications, with the exception of methadone, and were also less likely to align with requirements when imposed by states.
Orphines are 10 times more dangerous than fentanyl and are showing up in street drugs within the US.
This study evaluated the efficacy of semaglutide once-weekly in treatment-seeking patients with alcohol use disorder and comorbid obesity.
This report examines how existing CIC programs operate, funding strategies used to sustain their work and offers insights to help strengthen and expand CIC models nationwide.
In this large population based cohort, prenatal exposure to benzodiazepines or Z-hypnotics was not associated with an increased risk of psychiatric disorders in offspring.
As I write my first presidential column, I find myself reflecting on the journey that brought me to this role—the patients during my APPE at the San Antonio State Hospital who opened my eyes to why psychiatric pharmacy matters, the mentors who challenged and inspired me as a student, resident, and throughout my career, and the dedicated volunteers and staff who make AAPP's work possible.
These results add to a growing body of evidence that CB1 neutral antagonists can attenuate the rewarding properties of opioids while sparing their therapeutically desirable antinociceptive effects, providing support for further investigation of CB1 neutral antagonists as possible treatments for OUD.
In this study estimating the effects of reducing federal funding for SSPs, the findings suggest that mortality will increase among persons who inject drugs during the 5 years after loss of funding.
Psychotherapy, including cognitive behavior therapy and motivational interviewing, offers short-term benefits; however, its long-term effectiveness is uncertain.
Adults with CUD seem to receive less stigma compared to adolescents with CUD, while stigmatizing attributions are produced less often when people have more contact with cannabis use and CUD.
In this study of hospitalized adults with OUD, treatment of opioid withdrawal with short-acting opioids exhibited a dose-dependent association with reduced hazard of early patient-directed discharge.
Very low certainty evidence suggests that, among people with opioid use disorder who have undergone withdrawal and wish to remain abstinent, a substantial percentage are willing to initiate naltrexone with marked early discontinuation.
Electronic screening alerts coupled with provider education increased the provision of medications for adolescents at risk for opioid-related harm.
Alcohol consumption, including at what may be perceived as “moderate” levels, is associated with increased mortality and morbidity risks.
No summary available
No summary available
The Drug Enforcement Administration is taking steps to temporarily ban supplements containing a synthetic version of kratom. The agency said it plans to classify an addictive psychoactive compound called 7-hydroxymitragynine, or 7-OH, in the same category as heroin and LSD — drugs that are illegal to buy or sell. This temporary scheduling action does not apply to botanical kratom products that contain naturally occurring 7-OH below the specified threshold.
These findings provide important reassurance regarding the safety of indicated paracetamol use during pregnancy.
Learn how psychiatric pharmacists implementing psychotropic stewardship in youth increases safety, follow up, and coordination of care while reducing health care costs.